Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Plos One|September 1, 2012
Both lethal and edema toxins of Bacillus anthracis disrupt the human dendritic cell chemokine networkAurélie Cleret-Buhot, Jacques Mathieu, Jean-Nicolas Tournier, et al.
Cellular Microbiology|January 17, 2007
Contribution of toxins to the pathogenesis of inhalational anthraxJean-Nicolas Tournier, Anne Quesnel-Hellmann, Aurélie Cleret, et al.
Vaccine|September 20, 2005
Evidence for adjuvanticity of anthrax edema toxinAnne Quesnel-Hellmann, Aurélie Cleret, Dominique R Vidal, et al.
Msphere|June 21, 2019
Questionable Efficacy of Therapeutic Antibodies in the Treatment of AnthraxJean-Nicolas Tournier, Clémence Rougeaux, Fabrice V Biot, et al.
Molecular Aspects of Medicine|June 30, 2009
Anthrax toxins: a weapon to systematically dismantle the host immune defensesJean-Nicolas Tournier, Silvia Rossi Paccani, Anne Quesnel-Hellmann, et al.
Plos One|June 30, 2012
Shape-based tracking allows functional discrimination of two immune cell subsets expressing the same fluorescent tag in mouse lung explantDaniel Fiole, Cédric Touvrey, Anne Quesnel-Hellmann, et al.
Scientific Reports|March 22, 2016
In vivo dynamics of active edema and lethal factors during anthraxClémence Rougeaux, François Becher, Eric Ezan, et al.
Infection and Immunity|May 28, 2015
Micropatterned macrophage analysis reveals global cytoskeleton constraints induced by Bacillus anthracis edema toxinYannick Trescos, Emilie Tessier, Clémence Rougeaux, et al.
The Journal of Infectious Diseases|June 3, 2006
Resident CD11c+ lung cells are impaired by anthrax toxins after spore infectionAurelie Cleret, Anne Quesnel-Hellmann, Jacques Mathieu, et al.
Vaccines|September 23, 2022
Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic ControlMarie Mura, Fabrice Simon, Vincent Pommier de Santi, et al.
Pageof 9